Interactions between lipoproteins and platelet membranes in obesity

Obesity

Volumn 17, Issue 7, 2009, Pages 1375-1380

  Raffaelli, Francesca ^a   Nanetti, Laura ^a   D'Angelo, Monica ^a   Montecchiani, Giorgio ^a   Alidori, Alessandro ^a   Montesi, Luca ^a   Faloia, Emanuela ^a   Vignini, Arianna ^a   Mazzanti, Laura ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CASE CONTROL STUDY; CELL MEMBRANE; CYTOLOGY; FEMALE; HUMAN; MALE; MEMBRANE FLUIDITY; METABOLISM; OBESITY; PHYSIOLOGY; THROMBOCYTE;

ADULT; BLOOD PLATELETS; CALCIUM-TRANSPORTING ATPASES; CASE-CONTROL STUDIES; CELL MEMBRANE; CHOLESTEROL; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MEMBRANE FLUIDITY; OBESITY; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRIGLYCERIDES;

EID: 67650074523     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.654     Document Type: Article

References (38)

1. Istituto Superiore di Sanita Workshop, Nutritional and genetic factors Involved in the obesity and in Its clinical complications, istituto Superiore di Sanità. Rome, October 22,2004. Proceedings edited by Massimo D'Archivio and Roberta Masella 2005, 51 p, Rapporti ISTISAN 05/17 (in Italian).
2. World Health Organization, Obesity: Preventing and managing the global epidemic, [WHO Technical report series No, 894], World Health Organization: Geneva, 2000.
3. Poirier P, Giles TD, Bray GA et al. American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism, Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism, Circulation 2006;113:898-918.
4. Rexrode KM, Manson JE, Hennekens CH. Obesity and cardiovascular disease, Curr Opin Cardiol 1996;11:490-495.
5. Nieves DJ, Cnop M, Retzlaff B, Waiden CE, Brunzell JD, Knopp RH, Kahn SE. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 2003;52:172-179.
6. Despres JP, Moorjani S, Luplen PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease, Arteriosclerosis 1990; 10:497-511.
7. Tchernof A, Lamarche B, Prud'Homme D et al. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care 1996;19:629-637.
8. SasaharaT, YamashltaT, Sviridov D, Fldge N, Nestel P. Altered properties of high density lipoprotein subfractions in obese subjects, J Lipid Res 1997;38:600-611.
9. James RW, Brulhart-Meynet MC, Lehmann T, Golay A. Lipoprotein distribution and composition in obesity: their association with central adiposity, lnt J Obes Relat Metab Disord 1997;21:1115-1120.
10. Aviram M. Modified forms of low density lipoprotein and atherosclerosis, Atherosclerosis 1993;98:1-9.
11. Sowers JR. Obesity and cardiovascular disease, Clin Chem 1998;44: 1821-1825.
12. Kuno T, Hozumi M, Morlnobu T et al. Antioxidant vitamin levels in plasma and low density lipoprotein of obese girls, Free Radical Res 1998;28: 81-86.
13. Mutlu-Turkoglu U, Oztezcan S, Telci A et al. An increase in lipoprotein oxidation and endogenous lipid peroxides in serum of obese women, Clin Exp Med 2003;2:171-174.
14. Van Gaal LF, Zhang A, Steijaert MM, De Leeuw IH. Human obesity: from lipid abnormalities to lipid oxidation, lnt J Obes Relat Metab Disord 1995; 19: S21-S26.
15. Myara I, Alamowitch C, Michel O et al. Lipoprotein oxidation and plasma vitamin E in nondiabetlc normotensive obese patients, Obes Res 2003;11:112-120.
16. Ferretti G, Bacchetti T, Moroni C et al. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. J Clin Endocrinol Metab 2005;90:1728-1733.
17. Ferretti G, Rabini RA, Bacchetti T et al. Glycated low density lipoproteins modify platelet properties: a compositional and functional study. J Clin Endocrinol Metab 2002;87:2180-2184.
18. Osamah H, Mira R, Sorina S et al. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets, BrJ Clin Pharmacol 1997;44:77-83.
19. Surya I, Akkerman J-W, The influence of lipoproteins on blood platelets. Am Heart J 1993; 125:272-275.
20. Nanetti L, Vignini A, Raffaelli F et al. Platelet membrane fluidity and Na+/K+ ATPase activity in acute stroke, Brain Res 2008;1205:21-26.
21. Rabini RA, Vignini A, Salvolini E et al. Activation of human aortic endothelial cells by LDL from Type 1 diabetic patients: an in vitro study, Atherosclerosis 2002;165:69-77.
22. Bradford M, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem 1976;72:248-254.
23. Rabini RA, Ferretti G, Galassi R et al. Modified fluidity and lipid composition In lipoproteins and platelet membranes from diabetic patients, Clin Biochem 1994;27:381-385.
24. Mazzanti L, Staffolani R, Rabini RA et al. Modifications in platelet membrane transport functions in insulin-dependent diabetes mellitus and in gestational diabetes, Biochim Biophys Acta 1992;1139:65-69.
25. Fiske CH, Subarrow Y. The colorimetric determination of phosphorus J Biol Chem 1925;66:375-400.
26. Duportail G, Welnreb A. Photochemical changes of fluorescent probes in membranes and their effect on the observed fluorescence anisotropy values. Biochim Biophys Acta 1983;736:171-177.
27. Sheridan NP, Block ER. Plasma membrane fluidity measurements in intact endothelial cells: effect of hyperoxia on fluorescence anisotropies of 1 -[4-(trimethylamino)phenyl]-6-phenylhexa-1,3,5-triene, J Cell Physiol 1988;134:117-123.
28. Lentz BR, Burgess SW. A dimerization model for the concentration dependent photophysical properties of dlphenylhexatriene and its phospholipid derivatives, DPHpPC and DPHpPA, Biophys J 1989;56: 723-733.
29. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature 1993;362:801-809.
30. Akkerman JW. Platelet activation by low density lipoprotein and high density lipoprotein, Pathophysiol Haemost Thromb 2006;35:270-280.
31. Trip MD, Cats VM, van Capelle FJ, Vreeken J, Platelet hyperreactivity and prognosis in survivors of myocardial infarction, N Engl J Med 1990;322:1549-1554.
32. Aviram M, Modified forms of LDL and atherosclerosis, Atlierosclerosis 1993;98:1-9.
33. Yip HK, Liou CW, Chang HW, Lan MY, Liu JS, Chen MC. Link between platelet activity and outcomes after an ischemic stroke, Cerebrovasc Dis 2005;20:120-128.
34. Skou JC, Esmann M. The NaK-ATPase, J Bioenerg Biomembr 1992;24:249-261.
35. Faloia E, Garrapa GG, Martarelli D et al. Physicochemical and functional modifications induced by obesity on human erythrocyte membranes. Eur J Clin invest 1999;29:432-437.
36. Zakim D, interface between membrane biology and clinical medicine. Am J Med 1986;80:645-647.
37. Mazzanti L, Rabini RA, Salvolini E et al. Sialic acid, diabetes and aging: a study on the erythrocyte membrane, Metabolism 1997;46:59-61.
38. Rabini RA, Vignini A, Martarelli D et al. Evidence for reduction of pro-atherosclerotic properties in platelets from healthy centenarians, Exp Ger 2003;38:367-371.